Startups Canada Startup Boom similispharma@gmail.comJune 25, 20260 StartupsBy Kavita NairJune 25, 20267 min read Key Takeaways Investors scramble to position themselves for the next big thing Valuations…
Entrepreneurship Private Funding Markets Crash similispharma@gmail.comMay 22, 20260 EntrepreneurshipBy Priya SharmaMay 22, 20267 min read Key Takeaways Investors face plummeting valuations Founders scramble for lifelines Venture capitalists reassess…
Startups Warren Buffet Invests Big similispharma@gmail.comMay 17, 20260 StartupsBy Kavita NairMay 17, 20268 min read Key Takeaways Investors flock to Canadian tech stocks Berkshire Hathaway invests $2.65B Buffett…
Startups Canada Startups Shift To International Stocks similispharma@gmail.comApril 7, 20260 International stocks have been outperforming growth stocks in recent times, leaving many investors wondering what’s behind this trend. In Canada,…
Startups Canada Startups Outshine Crypto similispharma@gmail.comApril 5, 20260 The tech world has been abuzz with the rise and fall of cryptocurrencies, but amidst the chaos, a new narrative…
Startups Australia Startups Boosted By Better Home Finance similispharma@gmail.comApril 5, 20260 The Australian startup scene is abuzz with excitement as Better Home & Finance Holding, a leading player in the burgeoning…
Startups Vanguard ETF Shaping India Startups similispharma@gmail.comApril 4, 20260 As the Indian startup ecosystem continues to grow at an exponential rate, investors and entrepreneurs are constantly on the lookout…
Startups AbCellera Shaping Canada Startups similispharma@gmail.comApril 3, 20260 The biotech sector has been witnessing a significant surge, particularly in companies that are pioneering innovative therapeutic solutions. At the…
Startups UK Startups Beat Bears With 3 Big Stocks similispharma@gmail.comApril 2, 20260 As the UK’s startups scene continues to evolve, investors are growing increasingly cautious. The ongoing economic uncertainty and the looming…
Startups US Startups Face Stagflation Risk in Europe similispharma@gmail.comApril 1, 20260 As the world grapples with the threat of a looming economic downturn, a growing concern among investors and financial experts…